BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31663592)

  • 1. Multifunctional temozolomide-loaded lipid superparamagnetic nanovectors: dual targeting and disintegration of glioblastoma spheroids by synergic chemotherapy and hyperthermia treatment.
    Marino A; Camponovo A; Degl'Innocenti A; Bartolucci M; Tapeinos C; Martinelli C; De Pasquale D; Santoro F; Mollo V; Arai S; Suzuki M; Harada Y; Petretto A; Ciofani G
    Nanoscale; 2019 Nov; 11(44):21227-21248. PubMed ID: 31663592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-responsive lipid-based magnetic nanovectors increase apoptosis in glioblastoma cells through synergic intracellular hyperthermia and chemotherapy.
    Tapeinos C; Marino A; Battaglini M; Migliorin S; Brescia R; Scarpellini A; De Julián Fernández C; Prato M; Drago F; Ciofani G
    Nanoscale; 2018 Dec; 11(1):72-88. PubMed ID: 30357214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells.
    Minaei SE; Khoei S; Khoee S; Vafashoar F; Mahabadi VP
    Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():575-587. PubMed ID: 31029351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-Loaded Lipid Magnetic Nanoparticles for Combined Local Hyperthermia and Chemotherapy against Glioblastoma Multiforme.
    Beola L; Iturrioz-Rodríguez N; Pucci C; Bertorelli R; Ciofani G
    ACS Nano; 2023 Sep; 17(18):18441-18455. PubMed ID: 37698887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid Magnetic Nanovectors Promote Selective Glioblastoma Cell Death through a Combined Effect of Lysosomal Membrane Permeabilization and Chemotherapy.
    Pucci C; De Pasquale D; Marino A; Martinelli C; Lauciello S; Ciofani G
    ACS Appl Mater Interfaces; 2020 Jul; 12(26):29037-29055. PubMed ID: 32459082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
    Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
    Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Membrane-Coated Magnetic Nanocubes with a Homotypic Targeting Ability Increase Intracellular Temperature due to ROS Scavenging and Act as a Versatile Theranostic System for Glioblastoma Multiforme.
    Tapeinos C; Tomatis F; Battaglini M; Larrañaga A; Marino A; Telleria IA; Angelakeris M; Debellis D; Drago F; Brero F; Arosio P; Lascialfari A; Petretto A; Sinibaldi E; Ciofani G
    Adv Healthc Mater; 2019 Sep; 8(18):e1900612. PubMed ID: 31389193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of combined effect of hyperthermia and ionizing radiation on cytotoxic damages induced by IUdR-loaded PCL-PEG-coated magnetic nanoparticles in spheroid culture of U87MG glioblastoma cell line.
    Rezaie P; Khoei S; Khoee S; Shirvalilou S; Mahdavi SR
    Int J Radiat Biol; 2018 Nov; 94(11):1027-1037. PubMed ID: 29985733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment.
    Grillone A; Battaglini M; Moscato S; Mattii L; de Julián Fernández C; Scarpellini A; Giorgi M; Sinibaldi E; Ciofani G
    Nanomedicine (Lond); 2019 Mar; 14(6):727-752. PubMed ID: 30574827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of glioblastoma cancer cells to radiotherapy and magnetic hyperthermia by targeted temozolomide-loaded magnetite tri-block copolymer nanoparticles as a nanotheranostic agent.
    Minaei SE; Khoei S; Khoee S; Mahdavi SR
    Life Sci; 2022 Oct; 306():120729. PubMed ID: 35753439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Patient-Personalized Nanovector Based on Homotypic Recognition and Magnetic Hyperthermia for an Efficient Treatment of Glioblastoma Multiforme.
    De Pasquale D; Pucci C; Desii A; Marino A; Debellis D; Leoncino L; Prato M; Moscato S; Amadio S; Fiaschi P; Prior A; Ciofani G
    Adv Healthc Mater; 2023 Jul; 12(19):e2203120. PubMed ID: 37058273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma.
    Emamgholizadeh Minaei S; Khoei S; Khoee S; Karimi MR
    Int J Biochem Cell Biol; 2019 Mar; 108():72-83. PubMed ID: 30660689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme.
    Barbarisi M; Iaffaioli RV; Armenia E; Schiavo L; De Sena G; Tafuto S; Barbarisi A; Quagliariello V
    J Cell Physiol; 2018 Oct; 233(10):6550-6564. PubMed ID: 29030990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
    Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
    Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy.
    Pellosi DS; Paula LB; de Melo MT; Tedesco AC
    Mol Pharm; 2019 Mar; 16(3):1009-1024. PubMed ID: 30698450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of MIL-Modified Fe
    Pulvirenti L; Monforte F; Lo Presti F; Li Volti G; Carota G; Sinatra F; Bongiorno C; Mannino G; Cambria MT; Condorelli GG
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication and Characterization of Chitosan-Hyaluronic Acid Scaffolds with Varying Stiffness for Glioblastoma Cell Culture.
    Erickson AE; Lan Levengood SK; Sun J; Chang FC; Zhang M
    Adv Healthc Mater; 2018 Aug; 7(15):e1800295. PubMed ID: 29893067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles).
    Wu VM; Huynh E; Tang S; Uskoković V
    Acta Biomater; 2019 Apr; 88():422-447. PubMed ID: 30711662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic hyperthermia therapy in glioblastoma tumor on-a-Chip model.
    Mamani JB; Marinho BS; Rego GNA; Nucci MP; Alvieri F; Santos RSD; Ferreira JVM; Oliveira FA; Gamarra LF
    Einstein (Sao Paulo); 2020; 18():eAO4954. PubMed ID: 31939525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Efficiency of Multiple Applications of Magnetic Hyperthermia Technique in Glioblastoma Using Aminosilane Coated Iron Oxide Nanoparticles: In Vitro and In Vivo Study.
    Rego GNA; Nucci MP; Mamani JB; Oliveira FA; Marti LC; Filgueiras IS; Ferreira JM; Real CC; Faria DP; Espinha PL; Fantacini DMC; Souza LEB; Covas DT; Buchpiguel CA; Gamarra LF
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.